Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma

Figure 10

Relations between the abundance of tumor-infiltrating lymphocytes (TILs) and SHMT2 expression, including (a) Type 1 T helper cell, (b) nature killer cell, (c) T follicular helper cell, (d) active B cell, (e) immature B cell, (f) active CD4 T cell, (g) Type 17 T helper cell, (h) Tem CD8, and (i) CD56 dim nature killer cell.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)